These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Gene polymorphisms of macrophage migration inhibitory factor affect susceptibility to chronic hepatitis B virus infection in an Iranian cohort. Author: Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Hashemi M. Journal: Microbiol Immunol; 2016 Jun; 60(6):390-6. PubMed ID: 27079941. Abstract: Macrophage migration inhibitory factor (MIF), a key proinflammatory mediator, plays important roles in chronic diseases. In this study, an attempt was made to clarify the associations between some functional polymorphisms such as MIF-173 G/C, MIF 95 bp and 189 bp insertion/deletion (I/D) polymorphisms and chronic hepatitis B virus (HBV) infection. Polymorphisms were assessed in 221 HBV patients and 200 normal subjects. MIF-173 G/C and MIF 95 bp and 189 bp I/D polymorphisms were genotyped using PCR-RFLP and PCR, respectively. When allele and genotype frequencies of the variants were compared between patients and controls by the χ(2) test, it was found that the frequency of MIF-173 G/C genotypes differed significantly between patients with chronic HBV and healthy controls (P < 0.05). Carriers of the MIF -173-C allele were at significantly higher risk of HBV infection than carriers of the MIF -173-G allele (P = 0.009, OR = 1.549, 95% CI = 1.114 - 2.155). Moreover, 95 bp I/D polymorphism was not associated with CP and the 185 bp I/D variant was not polymorphic in our group of subjects. The frequency of haplotypes did not differ significantly between groups (χ(2) = 11.391, P = 0.181). Our results suggest that MIF -173 G/C variant increases the risk of HBV in Iranian subjects. Further studies with larger sample sizes and different ethnicities are required to validate our findings.[Abstract] [Full Text] [Related] [New Search]